|
2021 Guidance Range, 2021 Actual Results, and 2022 Guidance Range |
||||||
|
|
|
2021 Updated Guidance Range |
|
2021 Actual Results |
|
2022 Guidance Range |
|
Organic Growth |
|
|
|
|
|
|
|
New Stores |
|
34 to 38 |
|
23 |
|
Up to 45 |
|
Raze-and-Rebuilds |
|
31 |
|
27 |
|
Up to 35 |
|
Fuel Contribution |
|
|
|
|
|
|
|
Retail fuel volume per store (K gallons APSM) |
|
232 to 238 |
|
229 |
|
235 to 245 |
|
Store Profitability |
|
|
|
|
|
|
|
Merchandise contribution ($ Millions) |
|
$690 to $700 |
|
$702 |
|
$740 to $760 |
|
Retail station OPEX excluding credit card fees and rent expense ($K, APSM) |
|
$28 to $29 |
|
$29 |
|
$29.5 to $31 |
|
Corporate Costs |
|
|
|
|
|
|
|
SG&A ($ Millions per year) |
|
$190 to $200 |
|
$194 |
|
$200 to $210 |
|
Effective Tax Rate |
|
24% to 26% |
|
24% |
|
24% to 26% |
|
Capital Allocation |
|
|
|
|
|
|
|
Capital expenditures ($ Millions) |
|
$325 to $375 |
|
$278 |
|
$350 to $400 |
Cowen & Co. Initiates Coverage On Aadi Bioscience with Outperform Rating
Cowen & Co. analyst Boris Peaker initiates coverage on Aadi Bioscience (NASDAQ:AADI) with a Outperform rating.
